Brain Surgery Services
Our board-certified neurosurgeons offer the full spectrum of brain surgery — from minimally invasive pituitary surgery to complex craniotomy and deep brain stimulation. Serving Hampton, GA and all of Southern Georgia.
Brain Surgeries We Perform
Brain Tumor Surgery (Craniotomy)
Surgical removal of brain tumors using microsurgical techniques, intraoperative navigation, and awake craniotomy when indicated. Published studies report 70–98% gross total resection rates depending on tumor type, with median survival for glioblastoma increasing from 12.1 to 14.6 months with Stupp protocol (surgery + chemoradiation).
- 70–98% gross total resection
- Image-guided neuronavigation
- Awake craniotomy available
- Same-day ICU monitoring
Deep Brain Stimulation (DBS)
Implantable neurostimulation device for treatment-resistant movement disorders. The landmark DBSNS trial and EARLYSTIM trial demonstrated 50–70% improvement in motor UPDRS scores for Parkinson's disease at 5 years. Tremor reduction of 80–90% in essential tremor (STAR trial). FDA-approved for Parkinson's, essential tremor, dystonia, OCD, and epilepsy.
- 50–70% motor improvement (Parkinson's)
- 80–90% tremor reduction (ET)
- Adjustable and reversible
- FDA-approved for 5 conditions
Epilepsy Surgery
Surgical treatment for drug-resistant epilepsy including temporal lobectomy, lesionectomy, and responsive neurostimulation (RNS). The landmark RCT by Wiebe et al. (NEJM 2001) showed 58% seizure freedom at 1 year with temporal lobectomy vs. 8% with medical therapy alone. Long-term studies show 50–80% seizure freedom at 5–10 years.
- 58% seizure-free at 1 year (RCT)
- 50–80% long-term seizure freedom
- RNS for non-resectable foci
- Reduces anti-seizure medications
Pituitary Surgery (Transsphenoidal)
Minimally invasive endoscopic endonasal transsphenoidal approach for pituitary adenomas and Rathke's cleft cysts. Remission rates are 80–90% for microadenomas (< 1 cm) and 50–60% for macroadenomas (≥ 1 cm) secreting growth hormone or cortisol. Visual improvement occurs in 80–90% of patients with preoperative visual field deficits.
- 80–90% remission (microadenomas)
- No external incision
- 80–90% visual improvement
- 1–2 day hospital stay
Cerebrovascular Surgery
Surgical treatment of brain aneurysms, arteriovenous malformations (AVMs), cavernous malformations, and moyamoya disease. The ISAT trial demonstrated comparable outcomes between microsurgical clipping and endovascular coiling for ruptured aneurysms. AVM cure rates with microsurgery are 94–100% for Spetzler-Martin grades I–III.
- 94–100% AVM cure (grades I–III)
- Aneurysm clipping & coiling
- Stroke prevention
- Microsurgical expertise
Skull Base Surgery
Complex neurosurgical approaches for tumors and lesions at the skull base, including meningiomas, acoustic neuromas (vestibular schwannomas), and chordomas. Gross total resection is achieved in 70–90% of acoustic neuromas with facial nerve preservation in 90–95% of cases at experienced centers.
- 70–90% gross total resection
- 90–95% facial nerve preservation
- Hearing preservation when possible
- Multidisciplinary team approach
Trigeminal Neuralgia Surgery
Microvascular decompression (MVD) is the gold standard surgical treatment for trigeminal neuralgia, offering 80–90% initial pain freedom and 70–75% sustained relief at 10 years. Alternative procedures include percutaneous rhizotomy (balloon compression, glycerol, radiofrequency) and stereotactic radiosurgery.
- 80–90% initial pain freedom
- 70–75% relief at 10 years
- Addresses root cause
- Outpatient options available
Brain Surgery by the Numbers
Our treatment recommendations are guided by the highest-quality neurosurgical evidence, including landmark randomized controlled trials and FDA-approved device studies.
DBS Clinical Trial Data
Deep Brain Stimulation outcomes from the EARLYSTIM, DBSNS, and STAR trials — the largest multicenter studies of neurostimulation for movement disorders.
- 50–70% motor UPDRS improvement at 5 years (PD)
- 80–90% tremor reduction (essential tremor)
- FDA-approved for 5 conditions
- Reduces Parkinson's medication by 50%+
Epilepsy Surgery Evidence
The Wiebe RCT (NEJM 2001) established temporal lobectomy as a level 1 evidence treatment for drug-resistant temporal lobe epilepsy.
- 58% vs 8% seizure-free (surgery vs medical)
- 7× improvement over medication alone
- 50–80% long-term seizure freedom
- RNS: 50–70% seizure reduction
Tumor & Skull Base Outcomes
Modern neurosurgical techniques including neuronavigation, intraoperative MRI, and microsurgery have dramatically improved tumor resection and functional preservation rates.
- 70–98% gross total resection (craniotomy)
- 80–90% visual improvement (pituitary)
- 90–95% facial nerve preservation (skull base)
- 94–100% AVM cure (grades I–III)
Statistics from published peer-reviewed studies including the EARLYSTIM trial (Lancet Neurology), Wiebe RCT (NEJM), STAR trial, ISAT trial, and meta-analyses of neurosurgical outcomes. Individual outcomes vary based on patient factors and condition severity.
MRI Review for Brain Conditions
Not sure if you need brain surgery? Our neurosurgeons offer MRI reviews to help you understand your diagnosis and treatment options — in person or via telemedicine.
Request Your MRI ReviewAdvanced Technology for Better Outcomes
We leverage cutting-edge neurosurgical technology to maximize outcomes and minimize risk for every brain surgery patient.
Image-Guided Surgery
Advanced neuronavigation and intraoperative imaging allow our surgeons to precisely target lesions while preserving critical brain structures — improving resection rates and reducing complications.
Technologies Used
- Stereotactic Neuronavigation
- Intraoperative Neurophysiology
- Awake Craniotomy Mapping
- Endoscopic Endonasal Technique
- Frameless Stereotaxy
Ideal for: Brain tumors, skull base lesions, epilepsy foci localization, and functional neurosurgery targets.
Neurostimulation Therapy
FDA-approved neurostimulation devices offer adjustable, reversible treatment for movement disorders and epilepsy — providing long-term symptom control without permanent tissue destruction.
Approved Indications
- Parkinson's Disease (Motor Fluctuations)
- Essential Tremor
- Dystonia
- Obsessive-Compulsive Disorder (OCD)
- Drug-Resistant Epilepsy (RNS/DBS)
Ideal for: Medication-resistant movement disorders, treatment-refractory epilepsy, and patients seeking non-destructive neuromodulation.
Brain Conditions We Treat
Brain Health Blog
Understanding Brain Tumors: Types, Symptoms & Treatment
Read ArticleDeep Brain Stimulation for Parkinson's Disease
Read ArticleEpilepsy Surgery: When Medication Isn't Enough
Read ArticlePituitary Tumor Treatment Guide
Read ArticleTrigeminal Neuralgia: Causes & Surgical Options
Read ArticleConcussion Management & When to See a Neurosurgeon
Read ArticleBrain Surgery FAQ
Ready to Discuss Your Brain Condition?
Schedule a consultation with our board-certified neurosurgeons. We offer MRI reviews, second opinions, and comprehensive treatment plans for all brain conditions.
Brain Care Across Georgia
Explore our spine services, accepted insurance plans, and the Georgia communities where we treat brain and neurosurgical patients.
Brain and Spine Specialists of Georgia provides spine surgery and neurosurgical brain care to patients throughout metro Atlanta and Middle Georgia, including Hampton, Lovejoy, McDonough, Stockbridge, Fayetteville, Griffin, and surrounding communities. We accept most major insurance plans including Medicare, Medicaid, Blue Cross Blue Shield, Aetna, Cigna, United Healthcare, Humana, and Tricare.